Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/048752external-prioritypatent/WO2012027328A2/en
Application filed by Univ TexasfiledCriticalUniv Texas
Publication of MA35686B1publicationCriticalpatent/MA35686B1/en
La présente invention concerne des anticorps humains, de préférence des anticorps humains recombinants, à la fois humanisés et chimériques, qui se lient spécifiquement aux ox40 humains. Les anticorps préférés présentent une affinité élevée pour le récepteur ox40 qu'ils activentThe present invention relates to human antibodies, preferably recombinant human antibodies, both humanized and chimeric, that specifically bind to human ox40s. Preferred antibodies have a high affinity for the ox40 receptor that they activate
MA35759A2010-08-232013-03-20
Anti-ox40 Antibodies and Methods of Use
MA35686B1
(en)